(Q51575779)

7 April 2018

title

The effect of selective phosphodiesterase inhibitors on plasma insulin concentrations and insulin secretion in vitro in the rat. (English)

1 reference

7 April 2018

1 reference

El-Metwally M

1

1 reference

7 April 2018

Shafiee-Nick R

series ordinal

2

1 reference

7 April 2018

Pyne NJ

series ordinal

3

1 reference

7 April 2018

Furman BL

series ordinal

4

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 April 1997

1 reference

7 April 2018

European Journal of Pharmacology

published in

1 reference

7 April 2018

volume

324

1 reference

7 April 2018

issue

2-3

1 reference

7 April 2018

page(s)

227-232

1 reference

7 April 2018

Effect of forskolin on islet cyclic AMP, insulin secretion, blood glucose and intravenous glucose tolerance in rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Theophylline prevents the inhibitory effect of prostaglandin E2 on glucose-induced insulin secretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Role of phosphodiesterase III in the antilipolytic effect of insulin in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Comparison of the glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

The Ionic, Electrical, and Secretory Effects of Endogenous Cyclic Adenosine Monophosphate in Mouse Pancreatic B Cells: Studies with Forskolin*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Effects of theophylline and dibutyryl cyclic adenosine monophosphate on the membrane potential of mouse pancreatic beta-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Metabolic and hormone-related responses to caffeine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

A novel insulin secretagogue is a phosphodiesterase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Characterization of the cDNA and gene encoding human PDE3B, the cGIP1 isoform of the human cyclic GMP-inhibited cyclic nucleotide phosphodiesterase family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Inhibition of glucose-induced insulin secretion by calcium channel blocking drugs in-vitro but not in-vivo in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Augmentation of glucose induced insulin secretion by pertussis vaccine, phentolamine and benextramine: involvement of mechanisms additional to prevention of the inhibitory actions of catecholamines in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Effect of intravenous aminophylline on plasma levels of catecholamines and related cardiovascular and metabolic responses in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

Control of insulin secretion: a model involving Ca2+, cAMP and diacylglycerol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900076-9

10.1016/S0014-2999(97)00076-9

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018